Search Results 1401-1410 of 11394 for anti-TNF drugs

1. Q702 For The Treatment Of Patients With Hematologic Malignancies - Mayo Clinic

   Q702 is in a class of medications called immunomodulatory agents. It works by helping the immune system kill cancer cells and by helping the bone marrow to ...

2. Stage 4 (Metastatic) Colon Cancer Clinical Trials - Mayo Clinic Research

   ... anti-EGFR containing regimens. The primary ... Drugs used in chemotherapy, such as TAS-102, work ... therapy selection tool for systemic therapy in CRC peritoneal ...

3. In Vitro 3D Cell Culture Models Validation For Tumor Drug Sensitivity After Tissue Removal - Mayo Clinic

   The purpose of this study is to validate that tumor organoid drug sensitivity is representative of patient treatment outcomes. Participation eligibility.

4. Neurology - Clinical trials

   Testing The Addition Of An Anti-cancer Drug, Selinexor, To The Usual Chemotherapy Treatment (Temozolomide) For Brain Tumors That Have Returned After Previous ...

5. Publications - Thomas M. Habermann, M.D. - Mayo Clinic

   Atallah-Yunes SA, Habermann TM, Khurana A. Targeted therapy in Burkitt lymphoma: Small molecule inhibitors under investigation. Br J Haematol. 2024 Jun; 204(6): ...

6. Promising developments in the search for glioblastoma therapies - Mayo Clinic

   Mayo Clinic is advancing the search for new glioblastoma treatments. Laboratory studies combining small molecule inhibitors with approved drugs have yielded ...

7. Gene Therapy Clinical Trials - Mayo Clinic Research

   This pivotal, open-label, single-arm study will evaluate the anti-cancer activity of ARQ 087 by Objective Response Rate (ORR) by central radiology review as per ...

8. Epicardial Delivery Of XC001 Gene Therapy To Promote Angiogenesis In CAD Patients Undergoing Treatment With CABG - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. Clinical trials - Oncology (Medical)

   The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...

10. Nilotinib and Combination Chemotherapy in Treating Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia - Mayo Clinic

    About this study. In this study researchers want to find out more about the side effects of a new drug for Philadelphia chromosome-positive (Ph+) acute ...